|
1) Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539-49
|
|
|
|
2) Abraham WT, Fisher WG, Smith AL, et al; MIRACLE Study Group. Cardiac resynchroni-zation in chronic heart failure. N Engl J Med. 2002; 346: 1845-53
|
|
|
|
|
|
3) Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350: 2140-50
|
|
|
|
|
|
4) Rivero-Ayerza M, Theuns DAMJ, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J. 2006; 27: 2682-8
|
|
|
|
|
|
5) Yu CM, Bleeker GB, Wing-Hong Fung J, et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005; 112: 1580-6
|
|
|
|
|
|
6) Cleland JGF, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. 2006; 27: 1928-32
|
|
|
|
|
|
7) Fish JM, Brugada J, Antzelevitch C. Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol. 2005; 46: 2340-7
|
|
|
|
|
|
8) Ermis C, Seutter R, Zhu AX, et al. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol. 2005; 46: 2258-63
|
|
|
|
|
|
9) Cleland JG, Nasir M, Tageldien A. Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called？ Nat Clin Pract Cardiovasc Med. 2007; 4: 90-101
|
|
|
|
|
|
10) Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol. 2004; 15: 544-9
|
|
|
|
|
|
11) Ghio S, Constantin C, Klersy C, et al. Inter-ventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J. 2004; 25: 571-8
|
|
|
|
|
|
12) Bax JJ, Marwick TH, Molhoek SG, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol. 2003; 92: 1238-40
|
|
|
|
|
|
13) Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004; 44: 1834-40
|
|
|
|
|
|
14) Yu CM, Fung JW, Zhang Q, et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004; 110: 66-73
|
|
|
|
|
|
15) Pitzalis MV, Iacoviello M, Romito R, et al; VENTAK CHF/CONTAK-CD Biventricular Pacing Study Investigators. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchro-nization therapy. J Am Coll Cardiol. 2005; 45: 65-9
|
|
|
|
|
|
16) Marcus GM, Rose E, Viloria EM, et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol. 2005; 46: 2208-14
|
|
|
|
|
|
17) Suffoletto MS, Dohi K, Cannesson M, et al. Novel speckle tracking radial strain from routine black-and-white echocardiography images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation. 2006; 113: 960-8
|
|
|
|
|
|
18) Yu CM, Abraham WT, Bax J, et al. Predictors of response to cardiac resynchronization therapy (PROSPECT) - study design. Am Heart J. 2005; 149: 600-5
|
|
|
|
|
|
19) Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy. Part 1-Issues before device implantation. J Am Coll Cardiol. 2005; 46: 2153-67
|
|
|
|
|
|
20) Bleeker GB, Bax JJ, Fung JWH. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006; 97: 260-3
|
|
|
|
|
|
21) Tang WH, Francis GS. Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection. Circulation. 2007; 115: 161-2
|
|
|
|
|
|
22) Lindenfeld J, Feldman AM, Saxon L, et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation. 2007; 115: 204-12
|
|
|
|
|
|
23) Diaz-Infante E, Mont L, Leal J, et al; SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol. 2005; 95: 1436-40
|
|
|
|
|
|
24) Bleeker GB, Kaandorp TA, Lamb HJ, et al; Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006; 113: 969-76
|
|
|
|
|
|
25) Tanno K, Miyoshi F, Watanabe N, et al. Are the MADIT II criteria for ICD implantation appro-priate for Japanese patients？ Circ J. 2005; 69: 19-22
|
|
|
|
|
26) Moss AJ, Zareba W, Hall J, et al; The Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) investigators. Prophylactic implan-tation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877-83
|
|
|
|
|
|
27) Bardy GH, Lee KL, Mark DB, et al; The Sudden Cardiac Death in Herat Failure Trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225-37
|
|
|
|
|
|
28) 循環器病の診断と治療に関するガイドライン(2005年度合同研究班報告)不整脈の非薬物治療ガイドライン(2006年改訂版)
|
|
|
|
|
|
29) McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007; 297: 2502-14
|
|
|
|
|
|
30) Linde C, Gold M, Abraham WT, et al; REVERSE Study Group. Rationale and design of a random-ized controlled trial to assess the safety and effi-cacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Am Heart J. 2006; 151: 288-94
|
|
|
|
|
|
31) Wilkoff BL, Cook JR, Epstein AE, et al; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002; 288: 3115-23
|
|
|
|
|
|
32) Curtis AB, Adamson PB, Chung E, et al. Biventricular Versus Right Ventricular Pacing in Patients with AV Block (BLOCK HF): Clinical Study Design and Rationale. J Cardiovasc Electrophysiol. 2007. Epub ahead of print
|
|
|
|
|